AI assistant
Sending…
PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2016
Jul 5, 2016
33488_dirs_2016-07-05_e9c4f14f-9aa3-4d5c-84c0-38f00c786fcf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2016-07-01
Reporting Person: CHARNAS ROBERT (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-01 | STOCK OPTION (RIGHT TO BUY) | $30.22 | A | 90000 | Acquired | 2026-06-30 | COMMON STOCK (90000) | Direct |
Footnotes
F1: The vesting commencement date ("Vesting Commencement Date) of the option is July 1, 2016. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer.
More from PUMA BIOTECHNOLOGY, INC.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8